[Bacteremia caused by quinolone-resistant Campylobacter jejuni in a patient with HIV infection]. 1994

R Elcuaz, and J F Lluch-Perales, and E Gómez, and J Suárez, and M Hernández, and B LaFarga

UI MeSH Term Description Entries
D008297 Male Males
D002169 Campylobacter Infections Infections with bacteria of the genus CAMPYLOBACTER. Campylobacter Infection,Campylobacteriosis,Infections, Campylobacter,Campylobacterioses,Infection, Campylobacter
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005759 Gastroenteritis INFLAMMATION of any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Causes of gastroenteritis are many including genetic, infection, HYPERSENSITIVITY, drug effects, and CANCER. Gastroenteritides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D012514 Sarcoma, Kaposi A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause. Kaposi Sarcoma,Kaposi's Sarcoma,Multiple Idiopathic Pigmented Hemangiosarcoma,Kaposis Sarcoma,Sarcoma, Kaposi's
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm

Related Publications

R Elcuaz, and J F Lluch-Perales, and E Gómez, and J Suárez, and M Hernández, and B LaFarga
October 2019, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,
R Elcuaz, and J F Lluch-Perales, and E Gómez, and J Suárez, and M Hernández, and B LaFarga
May 1996, Enfermedades infecciosas y microbiologia clinica,
R Elcuaz, and J F Lluch-Perales, and E Gómez, and J Suárez, and M Hernández, and B LaFarga
March 1990, Revista clinica espanola,
R Elcuaz, and J F Lluch-Perales, and E Gómez, and J Suárez, and M Hernández, and B LaFarga
January 1993, Enfermedades infecciosas y microbiologia clinica,
R Elcuaz, and J F Lluch-Perales, and E Gómez, and J Suárez, and M Hernández, and B LaFarga
August 1994, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
R Elcuaz, and J F Lluch-Perales, and E Gómez, and J Suárez, and M Hernández, and B LaFarga
January 1996, Enfermedades infecciosas y microbiologia clinica,
R Elcuaz, and J F Lluch-Perales, and E Gómez, and J Suárez, and M Hernández, and B LaFarga
April 1993, Medicina clinica,
R Elcuaz, and J F Lluch-Perales, and E Gómez, and J Suárez, and M Hernández, and B LaFarga
July 1998, Cancer control : journal of the Moffitt Cancer Center,
R Elcuaz, and J F Lluch-Perales, and E Gómez, and J Suárez, and M Hernández, and B LaFarga
February 1991, Presse medicale (Paris, France : 1983),
R Elcuaz, and J F Lluch-Perales, and E Gómez, and J Suárez, and M Hernández, and B LaFarga
December 1995, Enfermedades infecciosas y microbiologia clinica,
Copied contents to your clipboard!